Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents

被引:0
作者
Işıl Nihan Korkmaz
Hasan Özdemir
机构
[1] Atatürk University,Faculty of Science, Department of Chemistry
来源
Applied Biochemistry and Biotechnology | 2022年 / 194卷
关键词
Hydroxamic acid; Anticancer; HDAC inhibitors; Enzyme activity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6349 / 6366
页数:17
相关论文
共 299 条
  • [1] Fitzmaurice C(2015)The global burden of cancer 2013 JAMA Oncology 1 505-18
  • [2] Dicker D(2015)Human cancer databases (Review) Oncology Reports 33 3-165
  • [3] Pain A(2016)Current modalities in treatment of cancer Balıkesır Health Sciences Journal 5 154-234
  • [4] Hamavid H(2018)Anti-cancer activity of lobaric acid and lobarstin extracted from the antarctic lichen Stereocaulon alpnum Molecules 23 658-29304
  • [5] Moradi-Lakeh M(2006)Targeting multidrug resistance in cancer Nature Reviews Drug Discovery 5 219-514
  • [6] MacIntyre MF(2020)Mechanisms of multidrug resistance in cancer chemotherapy International Journal of Molecular Sciences 21 3233-1210
  • [7] Naghavi M(2007)Glutathione binding to the Bcl-2 homology-3 domain groove Journal of Biological Chemistry 282 29296-10031
  • [8] Pavlopoulou A(2005)Redox mechanisms of cytoprotection by Bcl-2 Antioxidants & Redox Signaling 7 508-589
  • [9] Spandidos DA(2005)Thioredoxin is related to life span regulation and oxidative stress response in Caenorhabditis elegans Genes to Cells 10 1203-9534
  • [10] Michalopoulos I(2016)Targeting thioredoxin reductase by parthenolide contributes to inducing apoptosis of HeLa cells Journal of Biological Chemistry 291 10021-77